Dapagliflozin explored in type 1 diabetes

Filed under: inpatient drug treatment centers

CHICAGO – Even as dapagliflozin's resubmitted application for marketing approval for treatment of type 2 diabetes is being scrutinized by the Food and Drug Administration, the drug is under study as a novel potential oral therapy for type 1 diabetes …
Read more on Clinical Endocrinology News Digital Network

Promising Cardiovascular Results from Major Diabetes Study

Filed under: inpatient drug treatment centers

A prominent University of Connecticut Health Center professor is the principal investigator in a clinical trial generating worldwide interest, in which a new diabetes drug was shown to be effective in lowering blood sugar without increasing the risk of …
Read more on UConn Advance (blog)